Serotonin Uptake InhibitorsAdrenergic Uptake InhibitorsAntidepressive AgentsParoxetineCitalopramAntidepressive Agents, TricyclicFluoxetineAntidepressive Agents, Second-GenerationSertralineCyclohexanolsDepressive DisorderSerotonin Plasma Membrane Transport ProteinsSerotonin SyndromeLofepramineSerotonin1-NaphthylamineDepressive Disorder, MajorReceptor, Serotonin, 5-HT1ADepressionSerotonin 5-HT2 Receptor AntagonistsSerotonin AntagonistsAbnormalities, Drug-InducedAutoreceptorsSerotonin Receptor AgonistsSuicideMid-Atlantic RegionReceptors, Serotonin, 5-HT18-Hydroxy-2-(di-n-propylamino)tetralinReceptors, SerotoninDrug Utilization ReviewDrug UtilizationPregnancy Complications5,7-DihydroxytryptamineDesipramineRaphe NucleiDrug InteractionsAnxiety DisordersAnti-Anxiety AgentsPregnancy TrimestersMonoamine Oxidase Inhibitors5-HydroxytryptophanDrug OverdoseSelf-Injurious BehaviorSexual Dysfunction, PhysiologicalDrug PrescriptionsRandomized Controlled Trials as TopicPindololReceptor, Serotonin, 5-HT2ACytochrome P-450 CYP2D6Psychotropic DrugsBehavior, AnimalMicrodialysisAnxietyPiperazinesPrenatal Exposure Delayed EffectsTreatment OutcomeBenzodiazepinesFetal DevelopmentDrug CostsPregnancyPsychiatric Status Rating ScalesDrug ApprovalSuicide, AttemptedFibromyalgiaDose-Response Relationship, DrugCognitive TherapyCase-Control StudiesDouble-Blind MethodAntipsychotic AgentsRisk FactorsPlacebosManaged Care ProgramsRats, Sprague-Dawley